Related Experiment Video
Updated: Jul 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A fatal case of suspected anaphylaxis with cefoperazone and sulbactam: LC-MS analysis
Kenji Tsujikawa1, Kenji Kuwayama, Hajime Miyaguchi
1First Chemistry Section, National Research Institute of Police Science, 6-3-1 Kashiwanoha, Kashiwa, Chiba 277-0882, Japan. tujikawa@nrips.go.jp
Abstract:
Cefoperazone and sulbactam are prescribed in combination and used in the treatment of moderate to severe bacterial infections. Serious anaphylaxis is a rare side effect. This report describes a fatal case of suspected anaphylaxis after intravenous administration of a combination of the two drugs. Heart blood was analyzed for cefoperazone by protein precipitation with acetonitrile and by liquid-liquid precipitation for sulbactam after protein precipitation with aqueous acetonitrile, followed by tandem mass spectrometry in the product ion scan mode for identification and by liquid chromatography mass spectrometry in the selected ion monitoring mode for quantitation. Calibration curves for cefoperazone and sulbactam were linear over the range 0.07 to 1.93 and 0.046 to 0.914 microg/ml respectively. The decedent's blood concentrations of cefoperazone and sulbactam were 0.368 and 0.143 microg/ml respectively. As these concentrations were below concentrations reported after single dosing studies and below those considered to be minimally inhibitory, death was presumed to have been caused by hypersensitivity and not an overdose. In conclusion, this procedure is useful for detecting and quantitating cefoperazone and sulbactam in postmortem blood and may be useful in the evaluation of anaphylaxis.
Insights
This case report details a fatal anaphylaxis reaction to cefoperazone and sulbactam. Postmortem blood analysis confirmed drug levels were not indicative of overdose, suggesting hypersensitivity as the cause of death.
Area of Science:
- Pharmacology
- Toxicology
- Clinical Medicine
Background:
- Cefoperazone and sulbactam combination therapy is used for moderate to severe bacterial infections.
- Serious anaphylaxis is a rare but potential adverse drug reaction.
Observation:
- A fatal case of suspected anaphylaxis occurred after intravenous administration of cefoperazone and sulbactam.
- Postmortem heart blood analysis was performed to quantify drug concentrations.
Findings:
- Liquid chromatography-tandem mass spectrometry was used to detect and quantify cefoperazone and sulbactam.
- Detected blood concentrations of cefoperazone (0.368 microg/ml) and sulbactam (0.143 microg/ml) were below reported therapeutic and minimally inhibitory levels.
- The cause of death was presumed to be hypersensitivity, not drug overdose.
Implications:
- The developed analytical method is effective for detecting and quantifying cefoperazone and sulbactam in postmortem blood.
- This methodology can aid in the forensic evaluation of suspected anaphylaxis cases involving these antibiotics.
More Related Videos
07:18Natural Product Discovery with LC-MS/MS Diagnostic Fragmentation Filtering: Application for Microcystin Analysis
Published on: May 31, 2019
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Clinical Significance of Antibiotic Resistance
Inhalation Anthrax